Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
Neuroscience and Biobehavioral Reviews
|
October 25, 2016
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato, Clare L Beasley, Margaret K Hahn, et al.
British Journal of Pharmacology
|
June 5, 2015
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors
Ian F Harrison, William R Crum, Anthony C Vernon, et al.
The Lancet. Psychiatry
|
April 30, 2017
Brain microglia in psychiatric disorders
Valeria Mondelli, Anthony C Vernon, Federico Turkheimer, et al.
Frontiers in Psychiatry
|
August 28, 2020
Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin
Bjørn Hanger, Amalie Couch, Lawrence Rajendran, et al.
CNS Drugs
|
September 25, 2020
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh, Juned Islam, Javad Khan, et al.
Neuroscience and Biobehavioral Reviews
|
May 10, 2015
The brain's code and its canonical computational motifs. From sensory cortex to the default mode network: A multi-scale model of brain function in health and disease
Federico E Turkheimer, Robert Leech, Paul Expert, et al.
Journal of Neurochemistry
|
August 24, 2007
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo
Anthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 3, 2006
Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo
Anthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
Psychoneuroendocrinology
|
May 25, 2018
Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue
Anita Calevro, Marie-Caroline Cotel, Sridhar Natesan, et al.
JAMA Psychiatry
|
July 9, 2025
Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders: A Review
Rachel Upthegrove, Fabiana Corsi-Zuelli, Amalie C M Couch, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
Neuroscience and Biobehavioral Reviews
|
October 25, 2016
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato, Clare L Beasley, Margaret K Hahn, et al.
British Journal of Pharmacology
|
June 5, 2015
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors
Ian F Harrison, William R Crum, Anthony C Vernon, et al.
The Lancet. Psychiatry
|
April 30, 2017
Brain microglia in psychiatric disorders
Valeria Mondelli, Anthony C Vernon, Federico Turkheimer, et al.
Frontiers in Psychiatry
|
August 28, 2020
Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin
Bjørn Hanger, Amalie Couch, Lawrence Rajendran, et al.
CNS Drugs
|
September 25, 2020
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh, Juned Islam, Javad Khan, et al.
Neuroscience and Biobehavioral Reviews
|
May 10, 2015
The brain's code and its canonical computational motifs. From sensory cortex to the default mode network: A multi-scale model of brain function in health and disease
Federico E Turkheimer, Robert Leech, Paul Expert, et al.
Journal of Neurochemistry
|
August 24, 2007
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo
Anthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 3, 2006
Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo
Anthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
Psychoneuroendocrinology
|
May 25, 2018
Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue
Anita Calevro, Marie-Caroline Cotel, Sridhar Natesan, et al.
JAMA Psychiatry
|
July 9, 2025
Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders: A Review
Rachel Upthegrove, Fabiana Corsi-Zuelli, Amalie C M Couch, et al.
Page
of 8